Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Unknown 4Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1Advanced Cancer 1

Interventions

Cyclophosphamide 1499Cisplatin 1435Paclitaxel 1340Radiotherapy 1310Carboplatin 1267Gemcitabine 1226Docetaxel 1133Bevacizumab 1070Fluorouracil 906Doxorubicin 805Dexamethasone 755Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 700Etoposide 679Irinotecan 639Filgrastim 624Cytarabine 587Nivolumab 586Leucovorin 583Vincristine 517Cetuximab 479Prednisone 478Bortezomib 474Trastuzumab 468Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 444Lenalidomide 436

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × indibulin × Clear all
NCT00591136 2012-07-19

Phase I Study of Indibulin in Patients With Solid Tumors

Alaunos Therapeutics

Phase 1 Completed
47 enrolled
Other solid neoplasm

Solid Tumors

NCT00591890 2012-07-19

Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans

Alaunos Therapeutics

Phase 1 Completed
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡